KHB

36Kr · Jan 28 at 08:00 AM

KHB: The holding subsidiary Tianlong Company has a comprehensive solution for Nipah virus testing

Wallstreetcn · Jan 26 at 05:15 AM

The A-share biopharmaceutical sector continues to strengthen, with Maccura, Hybribio Biotech, and KHB hitting the daily limit up in the afternoon. LIFERIVER and DAJY had previously reached their limit up, while WONDFO BIOTECH, ACROBIOSYSTEMS, Orient Biotech, and SSSW rose over 10%

Zhitong · Oct 29, 2025 at 11:43 AM

KHB: Net profit loss of 99.0801 million yuan in the third quarter, a decrease of 42.20%

Zhitong · Sep 18, 2025 at 07:56 AM

KHB's product has obtained a medical device registration certificate

Zhitong · Sep 17, 2025 at 08:40 AM

KHB convertible bond repurchase results announced, 70 bonds repurchased for a total amount of 7,016.87 yuan

Zhitong · Sep 4, 2025 at 05:52 AM

KHB and others established a medical technology company, including the sales business of bio-based materials